“Chimeric ScFv Monoclonal Antibody Composed of Tocilizumab-Light Chain, Heavy Chain, and Bacterial Flagellin for the Treatment of Autoimmune Disorder: Insilco Design and Cytotoxicity Study”. 2022. Journal of Pharmaceutical Negative Results, November, 644-59. https://pnrjournal.com/index.php/home/article/view/2794.